Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  JP Morgan Chase & Company    JPM

News SummaryMost relevantAll newsSector newsTweets

JPMORGAN CHASE & CO : Other Events, Financial Statements and Exhibits (form 8-K)

share with twitter share with LinkedIn share with facebook
share via e-mail
10/05/2017 | 10:37pm CEST

Item 8.01 Other Events

On October 5, 2017, JPMorgan Chase & Co. ("JPMorgan Chase") announced that in accordance with the terms of the outstanding warrants to purchase common stock of JPMorgan Chase, the warrant Exercise Price will be reduced to $41.834 per share, effective as of the close of business on October 6, 2017. A copy of the press release relating to this announcement is attached hereto as Exhibit 99.

Item 9.01 Financial Statements and Exhibits

(d) Exhibits

      Exhibit No.   Description of Exhibit

      99            JPMorgan Chase & Co. Press Release dated October 5, 2017



© Edgar Online, source Glimpses

share with twitter share with LinkedIn share with facebook
share via e-mail
08:48aDJJP MORGAN CHASE MPANY : Crisis-Era Securities Regain Investors' Favor -- WSJ
07:11a JP MORGAN CHASE MPANY : uses startup to help unlock its data
06:35a JP MORGAN CHASE MPANY : BBK wins 2017 JP Morgan Quality Recognition Award
06:09a JP MORGAN CHASE MPANY : JPMorgan reaches beyond its branches with new mobile acc..
05:02a JP MORGAN CHASE MPANY : JPMorgan partners with data start-up to boost fixed-inco..
10/22DJJP MORGAN CHASE MPANY : J.P. Morgan, United Renegotiating Card Partnership
10/20 JP MORGAN CHASE MPANY : JPMorgan Chase Announces 2017 Mid-Cycle Stress Test Disc..
10/20 JPMORGAN CHASE & CO : Material Modification to Rights of Security Holders, Amend..
10/20 Factbox - Impact on banks from Britain's vote to leave the EU
10/20 PayPal tops profit estimates, lifts target on mobile payments growth
More news
News from SeekingAlpha
02:58a JPMorgan, United talk over card deal
10/20 JPMORGAN : The Signs Of Higher Trading Revenue To Come
10/20 Will SPDR Dividend ETF SDY Underperform In 2018?
10/20 I Love Earnings Season! Let's See How Abbott Laboratories, Johnson & Johnson ..
10/20 Tracking Ken Fisher's Fisher Asset Management Portfolio - Q3 2017 Update